Abstract
Background
Toxicant associated fatty liver disease (TAFLD) is a recently identified form of non-alcoholic fatty liver disease (NAFLD) associated with exposure to industrial chemicals and environmental pollutants. Numerous studies have been conducted to test the association between industrial chemicals/ environmental pollutants and fatty liver disease both in vivo and in vitro.
Objectives
The objective of the paper is to report a list of chemicals associated with TAFLD.
Methods
Two federal databases of rodent toxicology studies– ToxRefDB (Environmental Protection Agency) and Chemical Effects in Biological Systems (CEBS, National Toxicology Program) were searched for liver endpoints. Combined, these two databases archive nearly 2000 rodent studies. TASH descriptors including fatty change, fatty necrosis, Oil red O positive staining, steatosis and lipid deposition were queried.
Results
Using these search terms, 123 chemicals associated with fatty liver were identified. Pesticides and solvents were the most frequently identified chemicals, while PCBs/dioxins were the most potent. About 44% of identified compounds were pesticides or their intermediates, and nearly 10% of pesticide registration studies in ToxRefDB were associated with fatty liver. Fungicides and herbicides were more frequently associated with fatty liver than insecticides.
Conclusions
More research on pesticides, solvents, metals and PCBs/dioxins in NAFLD/TAFLD is warranted due to their association with liver damage.
Keywords: TASH, NAFLD, ToxRefDB, CEBS, pesticides, steatosis, steatohepatitis
Introduction
The liver is the first-line of defense against potentially harmful xenobiotics, and it is therefore the target organ that is most commonly affected by commercially-produced chemicals and environmental pollutants. Indeed, 33% of the 677 most common workplace chemicals reported in the National Institute of Occupational Safety and Health Pocket Guide are associated with hepatotoxicity (Tolman, 1998). The pathologic liver lesions associated with chemical exposures are myriad and range from hepatitis, fibrosis and cirrhosis to liver cancer (Cave, 2011). However, following the description of toxicant associated fatty liver disease (TAFLD) and its more severe form, toxicant associated steatohepatitis (TASH), it now appears that fatty liver may be the most common pathologic hepatic response to chemical exposure (Cave et al., 2012, Wahlang et al., 2013, Cave et al., 2011b, Cave, 2011, Brautbar and Williams, 2002). Identifying TAFLD/TASH in humans is challenging for several reasons. The entity is clinically under-recognized; routine clinical biomarkers are insensitive; and out of the 88 million substances registered with the Chemical Abstracts Service (CAS) by 2014, there is no comprehensive list of chemicals correlated with TAFLD (CAS, 2014). As such, TAFLD is a clinicopathologic diagnosis which relies on histologic examination.
We have recently reviewed pathologic grading and staging systems and known molecular mechanisms of fatty liver disease (Wahlang et al., 2013). The term “TASH” was initially coined in 2010 to describe steatohepatitis in human vinyl chloride workers (Cave et al., 2010b). Liver biopsies from highly exposed workers resembled those from obese subjects (nonalcoholic steatohepatitis - NASH) or alcoholics (alcoholic hepatitis – ASH), although these workers were neither obese nor consumed alcohol. Relatively more is known about histologic abnormalities in NASH, and this is primarily driven by pharmaceutical clinical trials including the National Institutes of Health (NIH) sponsored NASH Clinical Research Network (Kleiner et al., 2005). The NASH CRN uses, in part, histological improvement to determine the efficacy of experimental medications. Important pathologic lesions including steatosis, inflammation, and fibrosis have been included in these studies. Steatosis has been defined as an accumulation of triglycerides in at least 5% of hepatocytes (Aly and Kleiner, 2011; Canet et al., 2012). The transition from steatosis to steatohepatitis is characterized by centrilobular (zone 3) centered injury and lobular inflammation (lymphocytes with neutrophils and activated Kupffer cells), hepatocyte ballooning and Mallory-Denk bodies and fibrosis (Kleiner and Brunt, 2012). While these findings are typically present on hemotoxylin and eosin (H&E), stained slides, other stains have been used such as Oil-Red-O which stains lipid droplets to quantify steatosis. Similar pathologic lesions have been observed in human TASH and in rodent models of steatohepatitis (Wahlang et al., 2013).
TASH development may have similar mechanisms to other forms of fatty liver disease. TASH may be a progressive “two hit model” in which the “second hit” occurs on the background of steatosis and involves the elevation of inflammatory cytokines, mitochondrial dysfunction, insulin resistance, and oxidative stress which causes steatohepatitis and fibrosis (Day and James, 1998, Yilmaz, 2012). With time and persistence of exposure to these conditions, which can arise secondary to chemical exposure, steatohepatitis may progress to fibrosis and cirrhosis (Wahlang et al., 2013, Cave et al., 2010b, Cave et al., 2011a).
Rodent models are widely utilized to study steatohepatitis. However these models typically do not recapitulate all aspects of the human diseased form (McGonigle and Ruggeri, 2014). In general, some rodent models tend to predominantly develop steatosis rather than inflammation and fibrosis (Bieghs and Shiri-Sverdlov, 2014). While many chemical exposure studies in rodents in the literature have reported the development of steatosis descriptors, the significance of these findings were not appreciated. This is because steatosis was erroneously believed to be a benign finding, at least prior to the description of NASH in 1980 (Ludwig et al., 1980) and certainly TASH in 2010. The purpose of this study is to provide a list of chemicals that impact hepatic steatosis based on previously published rodent studies. A searchable archive of rodent studies provided in the websites of US Environmental Protection agency (EPA) and the National Institute of Environmental Health Sciences (NIEHS) presented a unique opportunity to accomplish this objective. The identification of environmental chemicals associated with the development of TAFLD will enable subsequent mechanistic animal studies and clinical translation in exposed humans.
Materials and Methods
Searchable databases
Two comprehensive chemical exposure and rodent pathology databases managed by the United States federal government were accessed for this study. The first was the EPA database known as ToxRefDB or the Toxicological Reference Database which was designed by the National Center for Computational Toxicology (NCCT) and the EPA Office of Pesticide Programs (OPP) which includes the past 30 years’ pesticide registration toxicity data and $2 billion of animal studies results (EPA, 2013). Using standardized vocabulary, ToxRefDB warehouses detail study design, dosing, and observed treatment-related effects. The ToxRefDB also stores chemical toxicity data in detail through freely accessible and searchable databases (EPA, 2013). ToxRefDB also connects with the ACToR (Aggregated Computational Toxicology Resource) in order to link it with public hazard, exposure and risk resources (EPA, 2013). Furthermore, ToxRefDB is connected to ToxCast, another EPA database and a high throughput screening tool that links exposure to biological processes affected by chemicals (EPA, 2013). ToxRefDB allows users to search congregate and group chemicals depending on the toxicological outcomes that are specific to the type of the study, target organ/effect categories (e.g., tumorigenicity) (Martin et al., 2007). ToxRefDB classifies chemicals by their relative potency depending on specific endpoints/grouping of chemicals that also depends on the mechanism of action.
Currently, the ToxRefDB warehouses searchable pathologic information on 474 studies of pesticides and intermediates. In our study, the 474 rat/mouse studies were queried for histological NAFLD and TASH descriptors including “fatty change”, “Oil red O positive”, “steatosis”, and “lipid deposition”. The data were accessed in Fall 2013 at http://actor.epa.gov/toxrefdb/faces/Home.jsp. The following study types were queried: sub-chronic (SUB), chronic (CHR) and multigeneration reproductive (MGR). MGR are studies performed in rodents to identify parental and offspring systemic toxicity and the reproductive toxicity of pesticides, industrial chemicals and pharmaceuticals (Martin et al., 2009). The effect type selected was “pathology (non-neoplastic)”. The effect target was always the “liver” in the search and the effect descriptions were: “fatty change”, “lipid deposition”, “steatosis” and “Oil red O” positivity in increased effect direction (see supplemental material, ToxRefDB search instructions). Compounds selection was based on the altered NAFLD and TASH descriptors at the Lowest Effect Level (LEL). Compounds and their LELs were arranged and listed in tables.
The second rodent database utilized was the Chemical Effects in Biological Systems (CEBS) data repository developed by the National Toxicology Program (NTP) which warehouses about 9000 rodent toxicology studies (NTP). CEBS combines public toxicogenomics data including study design and timeline, clinical chemistry and histopathology, microarray and proteomics data (Waters et al., 2008). CEBS warehouses data from academic, industrial and governmental laboratories, and it was mainly developed to allow public and free search though these data and studies (Sciences, 2012, Waters et al., 2008). CEBS stores rats, mice and human subjects studies and it contains more than 4000 microarray hybridizations, and 75 2D gel images with protein identification (Waters et al., 2008). Furthermore, CEBS comprises more than 1500 animals’ clinical chemistry and histopathology data (Waters et al., 2008).
In Fall 2013, CEBS was accessed at: http://cebs.niehs.nih.gov. The queried assay domain was “histopathology” and the diagnoses selected were “fatty change” and “toxic hepatopathy” as the latter two terms appear to have been used to describe fatty liver in several National Toxicology Program (NTP) reports on polychlorinated biphenyls (PCBs) (National Toxicology, 2010). “Liver and all its parts” was always the target organ selected and all degrees of severity were included (see supplemental material, CEBS search instructions). The search initially returned 329 studies, but medications and natural products were subsequently manually excluded. Remaining compounds and their LELs were then arranged and listed in tables.
Results
ToxRefDB
At the Lowest Effect Level (LEL), 42 pesticides from 474 studies were associated with TAFLD pathologic descriptors including “fatty change”, “Oil red O positive”, “steatosis”, and “lipid deposition” (Tab. 1). The 42 compounds included 22 fungicides, 13 herbicides, 6 insecticides, and 1 miticide. These positive results came from both species (rat = 40 and mouse = 20) and from all queried study designs including sub-chronic (n = 16), chronic (n = 34) and multigeneration reproductive (n = 10). Thus nearly 10% of pesticide studies were associated with the development of TAFLD. Not all of these pesticides may be clinically relevant mediators of steatohepatitis due to the high LEL values reported in some cases. However, 6 pesticides had LELs less than 10 mg/kg/day, and that increases the likelihood that they could be clinically significant mediators of TAFLD depending on their crop application patterns. These pesticides were: cyproconazole, dazomet, fluazinam, hexaconazole, pyrasulfotole metapolite (SXX 0665) and acequinocyl. Cyproconazole, dazomet, fluazinam, flusilazole, hexaconazole, paclobutrazol, triadimefon, vinclozolin and fluthiacet-methyl pesticides were associated with the development of steatosis in more than one study. This reproducibility increases the likelihood that exposures to these chemicals do indeed result in steatosis. Two fungicides, dazomet and hexaconazole, were linked to steatosis in 3 studies and had LELs <10 mg/kg/day in at least 2 studies. Supplemental Table 1 lists the 395 chemicals and their studied doses that did not produce histologic descriptors of fatty liver disease in rodents in the ToxRefDB database.
CEBS
Three hundred twenty nine studies of 81 chemicals reported positive TAFLD descriptors (“toxic hepatopathy” and “fatty change”). These chemicals included 31 solvents, plasticizers, monomers, and chemical intermediates (Tab. 2); 14 miscellaneous chemicals (Tab. 3); 12 pesticides and pesticide intermediates (Tab. 4); 9 fragrances, cosmetics and essential oils (Tab. 5); 9 paints, polishes, dyes and food additives (Tab. 6); and 6 PCBs and dioxin-like molecules (Tab. 7). Several chemicals from each class produced steatosis with LELs ≤ 10 mg/kg (7/14 pesticides; 6/6 PCBs and dioxin-like compounds; 4/31 solvents, plasticizers, monomers, and chemical intermediates; 3/9 paints, polishes, and dyes; 3/14 miscellaneous chemicals; and 1/9 fragrances; cosmetics, and essential oils). In CEBS, steatosis was reported in 29 mouse studies and 57 rat studies including both acute (n =9) and chronic (n =72) exposure models.
Discussion
Between CEBS and ToxRefDB, 371 studies linked 123 environmental chemicals to fatty liver disease in rodents. Pesticides composed almost 44% (54/123) of these chemicals and 14/55 pesticides produced steatosis with LELs less than 10. According to the US Environmental Protection Agency, a pesticide is: “any substance or mixture of substances intended for preventing, destroying, repelling, or mitigating any pest.” Though often misunderstood to refer only to insecticides, the term pesticide also applies to herbicides, fungicides, and various other substances used to control pests. Pesticides are a double-edged sword because they increase crop yields while simultaneously contaminating the food supply. The liver is responsible for the detoxification of these xenobiotic compounds primarily through cytochrome P450 enzymes; such as CYP3A and CYP2B families, that initiate the first step of the detoxification process (Nebert and Gonzalez, 1987, Nelson et al., 1996). Thus, it is not surprising that the liver is a target organ for pesticide toxicity. Indeed many pesticides have previously been associated with fatty liver disease and aminotransferases elevation [reviewed in (Wahlang et al., 2013)].
The present study increases the understanding of the role of pesticides in steatohepatitis. In particular, the potential roles of fungicides and herbicides in steatohepatitis appear to have been previously underestimated. Fungicides and herbicides are widely used for agricultural, residential, and industrial purposes (Reigart, 2013). According to EPA, global annual fungicide application is nearly 500 million pounds (Reigart, 2013). Some azole antifungals including triadimefon, propiconazole and cyproconazole have been previously associated with hepatotoxicity and hepatomegaly in rats (Hester et al., 2006, Peffer et al., 2007). Interestingly, dazomet and hexaconazole were associated with fatty liver disease at relatively low LELs in multiple studies in ToxRefDB. Dazomet is a fungicide, herbicide and nematicide that in chronic mice studies produced hepatomegaly combined with large droplet steatosis (EPA, 2008, Authority, 1997). Hexaconazole is systemic triazole fungicide mainly used for the banana black and yellow sigatoka disease control (EPA, 1999). Hexaconazole was associated with hepatic enzyme elevation, hepatocellular hypertrophy, and hepatic fatty infiltration/changes in rodent and dog studies (EPA, 1999). Interestingly, in the present study, dazomet, hexaconazole, and 8 other pesticides in ToxRefDB were associated with steatosis descriptors in multi-generational reproductive studies. This may be the first evidence linking developmental pesticide exposures to fatty liver disease.
After pesticides, solvents were the class with the second highest number of chemicals (n=31) associated with steatosis in rodents. Solvents have been associated with hepatotoxicity since the late 1800s (Brautbar and Williams, 2002). Solvents are primarily used in industrial and military applications, but also have residential uses and contaminate the environment (Brautbar and Williams, 2002). Many solvents like vinyl chloride (VC) are halogenated hydrocarbons. Previous studies link exposure to VC and other haloalkanes/haloalkenes to steatohepatitis (Cave et al., 2012). Furthermore, a Brazilian study on volatile petrochemical mixtures demonstrated that these chemicals caused NASH in exposed plant workers (Cotrim et al., 1999). It is therefore not surprising than our study yielded 31 chemicals from this class, which has historically been the class most associated with steatohepatitis.
Paints, polishes and dyes have also previously been linked to liver disease. Abnormal serum transaminases have been reported in painters, but this may have been due to solvent co-exposures (Zimmerman, 1999, Dossing et al., 1983). Likewise, liver enzyme elevation was reported in 44% of shoe repairmen (Tomei et al., 1999). Moreover, Nigerian vat dye workers had increased serum transaminases levels (Soyinka et al., 2007). Three of the chemicals associated with TAFLD in CEBS were azo dyes. Azo dyes are used as well to color textile, fabric, leather and papers. Exposure to azo food dyes including tartrazine and carmoisine resulted in aminotransferase elevation in a rodent study (Amin et al., 2010). Four chemicals associated with TAFLD in this study are used for cosmetic purposes including hair coloring. Hair dyes have been proposed to influence the development of liver disease (Prince et al., 2010). The potential role of food coloring additives and cosmetics in the development of NASH is intriguing due to their widespread use, and more data are needed.
Five PCBs/dioxins were associated with steatosis descriptors in this study; and all had very low LELs. PCBs are polychlorinated hydrocarbons that were commercially produced in the 1930s–1970s (Silberhorn et al., 1990). PCBs are thermodynamically stable persistent organic pollutants, and thus PCB exposure remains relevant even though PCBs were banned in the 1970s. PCB exposures have been associated with suspected NALFD in epidemiological studies including the 2003–2004 adult National Health and Nutrition Examination Survey (NHANES) (Cave et al., 2010a). PCBs were also found to cause with hepatomegaly and slight increases in hepatic enzymes in workers in electrical capacitor factories in Taiwan (Yu et al., 1997). We recently demonstrated that a non-dioxin-like PCB, PCB 153, worsened diet induced obesity and steatosis and was associated with hepatic antioxidant depletion (Wahlang et al., 2011, Shi et al., 2012). Likewise, dioxins have been associated with hepatic steatosis, in part due to increased lipid transport into hepatocytes (Lee et al., 2010, Angrish et al., 2013, Angrish et al., 2012).
This study is not without several weaknesses, foremost of which are the pathologic descriptors used. While TAFLD is progressive disease characterized by steatosis, inflammation, and fibrosis, only steatosis descriptors were searched. “Steatohepatitis” is not a searchable term in either CEBS or ToxRefDB. Because inflammation/fibrosis queries could not be cross-matched with steatosis descriptors in CEBS/ToxRefDB, these terms were not included in the study as surrogates for steatohepatitis. This is because if hepatitis/fibrosis were present it would be unclear if the underlying disease was steatohepatitis or another other form of liver injury. Compounding the problem, precise terms for fatty liver disease such as steatosis were not available in some studies. Steatosis was not quantified and neither photomicrographs nor original publications were available on ToxRef/CEBS to allow for independent confirmation of the findings. Additionally, this study was solely dependent on pathologic descriptors and failed to address mode(s)-of-action. Potential human relevance, especially for compounds with high LEL’s is uncertain, and the effects of co-exposures (e.g. alcohol or high fat diet) were not addressed. Furthermore, only the lowest doses associated with fatty liver disease histologic descriptors are available at ToxRefDB. Determining chemicals not associated with fatty liver disease in CEBS was difficult due to the complexity of the database and lack of histologic descriptors for fatty liver disease in most of the chemicals studies.
Conclusions
From 371 studies archived in federal databases, 123 unique environmental chemicals were possibly linked to some form of fatty liver disease in rodents. Pesticides composed almost 44% of these chemicals. Thus, nearly 10% of pesticide registration toxicity studies reported the development of fatty liver disease. Some of these compounds were linked to liver disease at very low LELs, ≤ 10 mg/kg suggesting that these compounds could contribute to the development of steatohepatitis at environmentally relevant doses. Pesticides and solvents were the most frequently identified chemicals while PCBs/dioxins were the most potent (e.g. had the lowest LEL’s). Moreover, 395 chemicals were not associated with fatty liver disease at their studied doses in ToxRefDB. Given the high prevalence of both obesity and alcoholism, co-exposure to environmental chemicals, especially pesticides, may contribute to the development and progression of fatty liver disease. However, the effects of diet and alcohol on xenobiotic metabolism impacting TASH require further investigation. Therefore, these findings suggest that more research on the effects of pesticides, solvents, metals and PCBs/dioxins in steatohepatitis is required.
Supplementary Material
Table 1.
Chemical Name | Study Design and species | Administration route | MIRD* | LDT | HDT | LEL | Citation | |
---|---|---|---|---|---|---|---|---|
(mg/kg/day) | ||||||||
Fungicides: | ||||||||
1. | Bromuconazole | Mouse-Subchronic | Oral | 42937131 | 2.72 | 381 | 68.1 | Broadmeadow, A. (1990) LS860263: Toxicity Study by Dietary Administration to F-344 Rats for 13-Weeks: Final Report: Lab Project Number: RHA/192/860263: 88/RHA192/0888: 88/0888. Unpublished study prepared by Life Science Research Ltd. 323 p. |
2. | Cyproconazole | Rat-Chronic | Oral | 41164701 | 1.01 | 21.8 | 15.6 | Warren, S.; Carpy, S.; Muller, F. (1988) SAN 619 F: Chronic Toxicity/Oncogenicity Feeding Study in Rats: Project No. 357-R; Report No. CBK I.6858/87. Unpublished study prepared by Sandoz Ltd. 2225 p. |
Rat-MGR** | Oral | 40607723 | 0.28 | 13.3 | 8.29 | Eschbach, B.; Aerni, R.; Karapally, J.; et al. (1987) SAN 619F: 2-Generation Reproduction Study in Rats: Project No. 380-R; Report No. 6712/87. Unpublished study prepared by Sandoz, Ltd. 592 p. | ||
3. | Dazomet | Rat-Chronic | Oral | 41865001 | 0.2 | 4.83 | 3.71 | Kuhbroth, B. (1989) Report On The Oncogenic Potential Of Dazomet in Rats After 24 Month Administration in The Diet: Lab Project Number: 89/0277. Unpublished Study Prepared By Basf Aktiengeselschaft 1321 P. |
Mouse-Chronic | Oral | 41865101 | 3.9 | 95 | 69.9 | Kunbroth, B. (1989) Report On The Study Of The Oral Toxicity Of Dazomet Mice After 78 Week Administration in The Diet: Lab Project Number: 89/0341. Unpublished Study Prepared By Basf Ag. 10 P. | ||
Rat-MGR* | Oral | 41865301 | 0.46 | 19 | 2.78 | Hellwig, J. (1989) Report On The Reproduction Study With Dazomet in Rats; Continuous Dietary Administration Over 2 Generations (2 Litters in The First And 1 Litter in The Second Generation): Lab Project Number: 89/0051. Unpublished study prepared by Basf AG | ||
4. | Diethyl 4,4′-o-phenylenebis (3-thioallophanate) | Mouse-Chronic | Oral | 32674 | 0.48 | 300 | 300 | Hashimoto, Y. and Tsubura, Y. (1972) Final Report on the Chronic Oral toxicity studies of thiophanate-methyl, Dimethyl 4, 4′-O-phenylenebis(3-thioallophanate) in rats of Sprague-Dawley Strain for 24 months. Unpublished report from Nisso Institute for Life Sciences, Nippon Soda Co. Ltd. |
5. | Difenoconazole | Mouse-Chronic | Oral | 42090015 | 1.51 | 819 | 819 | Cox, R. (1989) CGA-169374 Technical: Oncogenicity Study in Mice: Final Report: Lab Project Number: 483-250. Unpublished study prepared by Hazleton Laboratories America, Inc. 2510 p. |
6. | Dimethomorph | Rat-Subchronic | Oral | 42233910 | 2.9 | 82 | 14.2 | Ruckman, S.; Crook, D.; Gopinath, C.; et al. (1987) Toxicity to Rats by Dietary Admixture for 13 Weeks with a 4-Week Withdrawal Period: Lab Project Number: CMK 7/8624. Unpublished study prepared by Huntingdon Research Centre Ltd. 259 p. |
7. | Famoxadone | Mouse-Chronic | Oral | 44302424 | 0.701 | 392 | 274 | Mackenzie, S. (1996) Oncogenicity Study With Dpx-Je874-221: Eighteen-Month Feeding Study in Mice: Lab Project Number: 526-95: Hlr 526-95: 9734-001. Unpublished Study Prepared By Haskell Lab. For Toxicology And Industrial Medicine. 1643 P. |
8. | Fenarimol | Rat-Chronic | Oral | 45502305 | 2 | 21.6 | 14.6 | Hoffman, D.; Gibson, W.; Pierce, E. et al. (1978) Twenty-Four Month Chronic Oral Toxicity of EL-222 (56722) in Rats Studies R-405 and R-415: Lab Project Number: 33428: 235173A. Unpublished study prepared by Lilly Research Laboratories. 399 p. |
Mouse-Chronic | Oral | 71920 | 7 | 86 | 86 | Hoffman, D.G.; Pierce, E.C.; Emmerson, J.L.; et al. (1978) Twenty-four Month Chronic Oral Toxicity of EL-222 (56722) in Mice: Studies M-9135 and M-9145. (Unpublished study received Sep 22, 1978 under 1471-EX-50; submitted by Elanco Products Co., Div. of Eli. Lilly & Co. | ||
9. | Fluazinam | Rat-Chronic | Oral | 42248620 | 0.04 | 53.0 | 40 | Mayfield, R.; Burton, S.; Crook, D.; Et Al. (1988) Fluazinam Technical (B1216): Potential Carginogenicity And Chronic Toxicity Study in Dietary Administration To Rats For 104 Weeks: Lab Project Number: Isk 8/87263. Unpublished Study Prepared By Huntingdon |
Rat-MGR* | Oral | 42248619 | 1.5 | 53.6 | 9.7 | Tesh, J.; Willoughby, C.; Fowler, J. (1987) Fluazinam Technical (B1216): Effects Upon Reproductive Performance Of Rats Treated Continuously Throughout Two Successive Generations: Lab Project Number: 87/Isk068/097. Unpublished Study Prepared By Life Sciences Research | ||
10. | Flusilazole | Rat-Subchronic | Oral | 0 | 2 | 70 | 55 | Pastoor et al. (1983) 90-day oral feeding study in rats. Haskell Labs sponsored by E.I. du Pont de Nemours and Co. |
Rat-Chronic | Oral | 40042112 | 0.4 | 13 | 13 | Pastoor, T. (1986) Long-term Feeding and Two-generation, Four-litter Reproduction Study in Rats with in H-6573: Haskell Laboratory Report No. 32-86 | ||
11. | Hexaconazole | Rat-Subchronic | Oral | 40944805 | 2.5 | 250 | 25 | Kinsey, D.; Hollis, K.; Chart, I.; et al. (1984) PP 523: 90-day Feeding Study in Rats including Individual Animal Data Supplement: Laboratory Project ID: CTL/P/1073 & CTL/P/1073S. Unpublished study prepared by Central Toxicology Laboratory, ICI America |
Rat-Chronic | Oral | 40944808 | 0.47 | 61 | 4.7 | Hext, P. (1988) Hexaconazole: Two Year Feeding Study in Rats including Individual Animal Data Supplement: Laboratory Project ID: CTL/P/1920. Unpublished study prepared by ICI Central Toxicology Laboratory, ICI Americas Inc. 2776 p. | ||
Rat-MGR* | Oral | 40944813 | 1.0 | 50 | 5 | Middleton, M. (1988) Hexaconazole: Two-generation Reproduction Study in the Rat including Individual Animal Data Supplement: Laboratory Project ID: CTL/P/1598. Unpublished study prepared by ICI Central Toxicology Laboratory. 1717 p. | ||
12. | Iprodione | Mouse-Chronic | Oral | 42825002 | 23 | 793 | 604 | Chambers, P.; Crook, D.; Gibson, W.; et al. (1993) Iprodione: Potential Tumorigenic Effects in Prolonged Dietary Administration to Mice: Lab Project Number: RNP 359/921240. Unpublished study prepared by Rhone-Poulenc Agrochimie, Huntingdon Research Centre |
13. | Propiconazole | Rat-Chronic | Oral | 129918 | 3.6 | 101 | 96.4 | Hunter, B.; Slater, N.; Heywood, R.; et al. (1982) CGA 64 250: Potential Tumorigenic and Toxic Effects in Prolonged Dietary Administration to Rats: CBG 193/8284 (Test No. 789023). Final rept. (Unpublished study received Jul 21, 1983 under 100-641 |
14. | Metalaxyl | Rat-MGR* | Oral | 71600 | 2.5 | 62.5 | 62.5 | Cozens, D.D.; Allen, P.A.; Clark, R.; et al. (1980) Effect of CGA 48-988 on Reproductive Function of Multiple Generations in the Rat: CBG 181/80254. (Unpublished study received Apr 15, 1981 under 100-607; prepared by Huntingdon Research Centre, England, |
15. | Oxytetracycline hydrochloride | Rat-Chronic | Oral | 159856 | 1250 | 2500 | 1250 | Us Public Health Service (1986) Toxicology And Carcinogenesis Studies Of Oxytetracycline Hydrochloride (Cas No. 2058-46-0) in F344/N Rats And B6C3F1 Mice: (Feed Studies): Technical Report Series No. 315: [NIH Publication No. 86-2571]: Draft. Unpublished |
16. | Paclobutrazol | Mouse-Chronic | Oral | 40762501 | 3.75 | 113 | 113 | Shaw, D. (1986) Paclobutrazol: 104 Week Oral (Dietary Administration) Combined Toxicity and Carcinogenicity Study in the Mouse with a 52 Week Interim Kill: Laboratory Project ID: CTL/C/1759A, B, C and E. Unpublished study prepared by Hazelton Laboratory |
Rat-MGR* | Oral | 40734303 | 2.5 | 62.5 | 62.5 | Wickramaratne, G. (1987) Paclobutrazol: Two Generation Reproduction Study in Rats including Individual Animal Data: Laboratory Project ID: CTL/P/1496 and CTL/P/1496S. Unpublished study prepared by ICI Central Toxicology Laboratory. 1953 p. | ||
17. | Propanoic acid, 2-(2,4-dichlorophenoxy)-, (R)- | Rat-Subchronic | Oral | 43915101 | 7 | 245 | 144 | Mellert, W.; Deckardt, K.; Kaufmann, W.; et al. (1995) Dichlorprop-P--Subchronic Oral Dietary Toxicity and Neurotoxicity Study in Wistar Rats: Lab Project Number: 50C0187/91158: 92/32/EEC. Unpublished study prepared by BASF AG 653 p. |
18. | Triadimefon | Rat-Chronic | Oral | 42153901 | 2.7 | 199 | 114 | Bomhard, E.; Schilde, B. (1991) MEB 6447: Chronic Toxicity and Cancerogenicity Studies on Wistar Rats with Administration in Diet over a Period of 105 Weeks: Lab Project Number: 20774: 101922. Unpublished study prepared by Bayer Ag., Dept. of Toxicology. |
Mouse-Chronic | Oral | 40752101 | 13.5 | 765 | 550 | Bomhard, E. (1986) MEB 6447: Carcinogenicity Study on NMRI Mice (21-Month Administration in the Feed): Report No. 87287. Unpublished study prepared by Bayer AG. 1190 p. | ||
19. | Triadimenol | Rat-Subchronic | Oral | 42192701 | 8 | 221 | 39.6 | Nishimura, N. (1983) Subacute Toxicity Study of KWG 0519 in Dietary Administration to Rats for 13 Weeks: Lab Project Number: 101939. Unpublished study prepared by Bozo Research Center Inc. 320 p. |
20. | Trifloxystrobin | Mouse-Chronic | Oral | 44496705 | 3.51 | 274 | 274 | Gerspach, R. (1997) 18-Month Carcinogenicity Study in Mice: Cga-279202 Tech: Lab Project Number: 943039: 705-97. Unpublished Study Prepared By Novartis Crop Protection, Ag. 1802 P. |
21. | Triflumizole | Mouse-Chronic | Oral | 156544 | 16.2 | 362 | 67.4 | Inoue, H. (1984) Chronic Feeding And Oncogenicity Studies in Mice With Nf-114: Rd-84114: Experiment No. 098 (026-001). Unpublished Study Prepared By Nippon Soda Co., Ltd. 2565 P. |
22. | Vinclozolin | Mouse-Chronic | Oral | 43254704 | 2.1 | 1410 | 1230 | Mellert, W. (1994) Toxicology Study Report: Carcinogenicity Study with Reg. No. 83 258: Vinclozolin in C57BL Mice Administration in the Diet for 18 Months: Lab Project Number: 80S0375/88112: 94/10278. Unpublished study prepared by BASF AG |
Rat-MGR* | Oral | 42581301 | 4.9 | 290 | 290 | Hellwig, J. (1992) Report Reproduction Study with Reg. No. 83 258 (Vinclozolin) in Rats Continuous Dietary Administration over 2 Generations (2 Litters in the First and 2 Litters in the Second Generation): Lab Project Number: 92/11251: 71R0375/88053. Unpubl. | ||
23. | Bensulide | Rat-Subchronic | Oral | 43919601 | 5 | 100 | 100 | Mulhern, M.; Hudson, P.; Snodgrass, E. (1992) Bensulide: 13 Week Subchronic Dietary Toxicity Study in Rats: Lab Project Number: 7948: 451068. Unpublished study prepared by Inveresk Research Int’l. 236 p. |
24. | Butafenacil | Rat-Chronic | Oral | 45426401 | 0.39 | 13 | 13 | Gespach, R. (1998) 24-Months Carcinogenicity And Chronic Toxicity Study in Rats: Cga-276854 Technical: Final Report: Lab Project Number: 951029: 851-95. Unpublished Study Prepared By Novartis Crop Protection, Inc. 2431 P. {Oppts 870.4300} |
25. | Chlorsulfuron | Rat Chronic | Oral | 40089316 | 2 | 405 | 309 | Stula, E. (1985) Two-year Rat Feeding Study and Two-generation Reproduction Study: Report No. HLR-662-85. Unpublished study prepared by Haskell Laboratory for Toxicology and Industrial Medicine, E. I. du Pont de Nemours & Co., Inc. 1712p. |
26. | Ethofumesate | Rat-Subchronic | Oral | 44093601 | 18.2 | 2310 | 1900 | Powell, L.; Copeland, A.; Copinath, C. et al. (1989) T510 Ethofumesate: Toxicity to Rats by Dietary Administration for 13 Weeks (According to OECD Guidelines): (Final Report): Lab Project Number: A89580: RKY 86/881321: RKY/86. Unpublished study prepared |
27. | Fluthiacet-methyl | Rat-Subchronic | Oral | 43348423 | 0.6 | 1420 | 216 | Potrepka, R.; Morrissey, R. (1993) 90-Day Dietary Toxicity Study with CGA-248757 Technical in Rats: Final Report: Lab Project Number: F-00066. Unpublished study prepared by CIba-Geigy Environmental Health Center. 572 p. |
Rat-Chronic | Oral | 43830017 | 0.2 | 368 | 130 | Potrepka, R.; Richter, A. (1995) Two-Year Dietary Chronic Toxicity/Oncogenicity Study With Cga-248757 Technical in Rats: Lab Project Number: F-00068. Unpublished Study Prepared By Ciba-Geigy Corp. 2430 P. | ||
Mouse-Chronic | Oral | 43830015 | 0.1 | 37 | 37 | Chang, J.; Morrissey, R. (1995) Cga-248757 Technical: 18-Month Dietary Oncogenicity Study in Mice: Final Report: Lab Project Number: F-00069. Unpublished Study Prepared By Ciba-Geigy Corp. 1530 P. | ||
Rat-MGR* | Oral | 43830016 | 1.59 | 388 | 31.8 | Gilles, P.; Hart, S. (1994) A Two-Generation Reproduction Study in Rats With Gca-248757 Technical: Final Report: Lab Project Number: F-00081. Unpublished Study Prepared By Ciba-Geigy Corp. 781 P. | ||
28. | Mesosulfuron-methyl | Mouse-Chronic | Oral | 45430403 | 10.6 | 1360 | 1360 | Seeberger, A. (2000) Mouse Dietary Oncogenicity (18 months) Study: AE F130060-Substance Technical: Lab Project Number: 2000.0279: 97.0176: C009460. Unpublished study prepared by Aventis Pharma Deutschland GmbH. 1983 p. |
29. | Oxadiazon | Rat-Chronic | Oral | 149003 | 0.5 | 193 | 50.9 | Kudo, S.; Takeuchi, T.; Hayashi, K.; Et Al. (1981) Twenty-Four Month Chronic Toxicity Study Of Oxiadiazon in Rats. Unpublished Translation Of Study Prepared By Nippon Institute For Biological Science And Institute Of Environmental Toxicology. 1082 P. |
30. | Pyrasulfotole metabolite (SXX 0665) | Rat-MGR* | Oral | 46246333 | 2.48 | 51.9 | 9.48 | PMRA; A Two-Generation Dietary Reproduction Study in Rats Using SXX 0665. Bayer Corporation, Agriculture Division, Stilwell, KS. Study number 91-672-KO, December 4, 2001. MRID 46246333. Unpublished |
31. | Rimsulfuron | Rat-Chronic | Oral | 42047701 | 1 | 568 | 121 | Keller, D. (1991) Combined Chronic Toxicity/Oncogenicity Study With in E9636-22: Two-Year Feeding Study in Rats: Lab Project Number: 8572-001: 559-90. Unpublished Study Prepared By E.I. Du Pont De Nemours And Co. 1802 P. |
32. | Sethoxydim | Mouse-Chronic | Oral | 100527 | 4.48 | 143 | 41.2 | Takaori, H.; Nishibe, T.; Tsubura, Y.; Et Al. (1981) Chronic Feeding Study Combined With Oncogenicity Study Of Np-55 in Mice. Final Rept. (Unpublished Study Received Apr 15, 1982 Under 7969-58, Prepared By Nippon Soda Co., Ltd., Japan, Submitted By Basf AG |
33. | Sulfentrazone | Rat Subchronic | Oral | 43004601 | 3.3 | 535 | 199 | Nye, D. (1993) Ninety-Day Feeding Study in Rats: F6285 Technical: Lab Project Number: A89-2881: 399: 162AF89143. Unpublished study prepared by FMC Corp. Toxicology Lab. 722 p. |
34. | Tepraloxydim | Rat-Subchronic | Oral | 44467137 | 22 | 440 | 383 | Mellert, W.; Deckardt, K.; Gembardt, C. et al. (1996) Report Reg. No. 191819: Subchronic Oral Toxicity Study in Wistar Rats: Administration in the Diet for 3 Months: Lab Project Number: 31S0459/91048: 96/10756: PCP01749. Unpublished study prepared by BAS AG |
35. | Thiazopyr | Rat-Subchronic | Oral | 42619722 | 0.07 | 227 | 201 | Naylor, M.; Ribelin, W. (1992) Additional Information Related to the Previously Submitted Study: 90 Day Study of MON 13200 Administered in Feed to Albino Rats ML-88-246/EHL 88146 (MRID 42275530): Lab Project Number: ML-88-246/EHL-88146: R.D. NO. 1063: R.D |
Insecticides: | ||||||||
36. | Buprofezin | Rat-Subchronic | Oral | 42935201 | 3.4 | 362 | 316 | Watanabe, M.; Todhunter, J. (1992) A 90-Day Oral Toxicity Study of Buprofezin in Rats: Lab Project Number: NNI-BUPROF-EUP-13: T-15. Unpublished study prepared by Preclinical Research Labs and Science Regulatory Services International. 164 p. |
37. | Chlorpyrifos-methyl | Mouse-Chronic | Oral | 44680602 | 0.0815 | 44 | 41.5 | Yoshida, A. Et Al. (1988) Chlorpyrifos-Methyl: 18-Month Oral Toxicity Study in Mice: Lab Project Number: Ghf-R-166. Unpublished Study Prepared By The Institute Of Environmental Toxicology. 934 P. |
38. | d-cis, trans-Allethrin | Mouse-Chronic | Oral | 41099602 | 14.4 | 382 | 350 | Mayfield, R.; Gopinathy, C.; Crook, D.; Et Al. (1989) Pynamin Forte: Potential Tumorigenic Effects in Prolonged Dietary Administration in Mice: Project Id Smo 247/881026. Unpublished Study Prepared By Huntingdon Research Centre Ltd. 980 P. |
39. | Fipronil | Rat-Subchronic | Oral | 42918643 | 0.07 | 24 | 19.9 | Holmes, P. (1993) M&B 46030: Toxicity Study By Dietary Administration To Cd Rats For 13 Weeks: Final Report: Lab Project Number: Rha/298/46030: 90/Rha298/0781: 90/0781. Unpublished Study Prepared By Life Sciences Research Limited. 292 P. |
40. | Tetramethrin | Rat-Subchronic | Oral | 42146403 | 5.83 | 214 | 57.9 | Hosokowa, S.; Hiromori, T.; Seki, T.; et al. (1981) Six-month Subchronic Toxicity Study of Neo-Pynamin Forte in Rats: Lab Project Number: IT-00-0139. Unpublished study prepared by Sumitomo Chemical Co., Ltd. 97 p. |
41. | Thiacloprid | Mouse-Chronic | Oral | 44927710 | 5.7 | 873 | 234 | Wirnitzer, U.; Geiss, V. (1998) YRC 2894: Oncogenicity Study in B6C3F1-Mice Administration in the Food Over 2 Years: Lab Project Number: 27247: T9059195: 108358. Unpublished study prepared by Bayer AG. 2028 p. |
Miticide: | ||||||||
42. | Acequinocyl | Mouse-Chronic | Oral | 45531911 | 2.7 | 86 | 7 | Waterson, L. (1994) AKD-2023 Technical Potential Tumorigenic and Toxic Effects in Prolonged Dietary Administration to Mice: Lab Project Number: AGK 29/961180. Unpublished study prepared by Huntingdon Life Sciences Ltd. 2100 p. {OPPTS 870.4300} |
Chemicals are arranged according in alphabetic order in each class and their LELs, study design and species are provided according to the screened ToxRefDB studies.
MIRD: Master Record Identifier (specific ID to EPA’s Office of Pesticide Programs
MGR: Multigeneration Reproductive
Table 2.
# | Chemical Name | Study Design and species | Adminstration route | Accession number | LDT | HDT | LEL | Citation |
---|---|---|---|---|---|---|---|---|
(mg/kg) | ||||||||
1. | 2,2-Bis(Bromomethyl)-1,3 propanediol | Rat-Chronic | Dosed feed | 002-01167-0012-0000-0 | 25,000 | 200000 | 25,000 | Toxicology and Carcinogenesis Studies of 2,2-Bis(Bromomethyl)-I,3-Propanediol (Fr-1138 ®), (Cas No. 3296-90-0) in F344/N Rats and B6c3f1 Mice (Feed Studies), U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health |
2. | 4-Vinyl-1-cyclohexene diepoxide | Rat-Chronic | DERMAL | 002-01522-0004-0000-6 | 50 | 100 | 50 | Toxicology and Carcinogenesis Studies of 4-Vinyl-L-Cyclohexene Diepoxide (Cas No. 106-87-6) in F344/N Rats And B6c3fi Mice (Dermal Studies), U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health |
3. | 4,4′-Thiobis(6-tert-butyl-m-cresol) | Mouse-Chronic | Dose feed | 002-01472-0005-0000-1 | 1000 | 250 | 250 | Toxicology and Carcinogenesis Studies of 4,4′-Thiobis6-tert-butyl-m-cresol) (Cas No. 96-69-5) in F344/N Rats and B6c3fl Mice (Feed Studies), U.S. Department of Health and human services, Public Health Service, National Institutes of Health |
4. | Alpha-Methylstyrene | Mouse-Chronic | Respiratory exposure whole body | 002-03029-0010-0000-7 | 600 | 100 | 300 | Toxicology And Carcinogenesis Studies of α-Methylstyrene (Cas No. 98-83-9) in F344/N Rats And B6c3f1 Mice (Inhalation Studies), National Toxicology Program, P.O. Box 12233, Research Triangle Park, NC 27709, November 2007, NTP TR 543, NIH Publication No. 08-4474, National Institutes of Health Public Health Service, U.S. Department of Health and Human Services |
5. | Dibutyl phthalate | Rat-Short term | Dose feed | 002-02002-0020-0000-8 | 40,000 | 2,500 | 5,000 | Toxicity Studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F Mice1, Daniel S. Marsman, D.V.M., Ph.D., Study Scientist, National Toxicology Program, Post Office Box 12233, Research Triangle Park, NC 27709, NIH Publication 95-3353, March 1995, United States Department of Health and Human Services, Public Health Service, National Institutes of Health |
6. | Divinylbenzene | Mouse-Chronic | Respiratory exposure whole body | 002-02098-0014-0000-6 | 100 | 10 | 10 | Toxicology and Carcinogenesis Studies of Divinylbenzene-Hp (Cas No. 1321-74-0) in F344/N Rats And B6c3f1 Mice (Inhalation Studies), National Toxicology Program, P.O. Box 12233, Research Triangle Park, NC 27709, November 2006, NTP TR 534, NIH Publication No. 07-4470, National Institutes of Health, Public Health Service, U.S. Department of Health And Human Services |
7. | Glycidol | Mouse-Short term | Gavage | 002-02212-0017-0000-7 | 200 | 25 | 100 | Toxicology and Carcinogenesis Study of Glycidol (Cas No. 556-52-5) in Genetically Modified Haploinsufficient P16ink4a/P19arf Mice (Gavage Study), National Toxicology Program, P.O. Box 12233, Research Triangle Park, NC 27709, November 2007, NTP GMM 13, NIH Publication No. 08-5962, National Institutes of Health, Public Health Service, U.S. Department of Health and Human Services |
8. | Isoprene | Rat-Chronic | Respiratory exposure whole body | 002-02324-0012-0000-6 | 7000 | 70 | 220 | Isoprene (CAS No. 78-79-5) Administered by Inhalation to F344/N Rats And B6C3F Mice 1, Ronald L. Melnick, Ph.D., Study Scientist, National Toxicology Program, Post Office Box 12233, Research Triangle Park, NC 27709, NIH Publication 94-3354, July 1994, United States Department of Health and Human Services, Public Health Service, National Institutes of Health |
9. | Resorcinol | Rat-Chronic | Gavage | 002-02771-0007-0000-6 | 150 | 50 | 50 | Toxicology and Carcinogenesis Studies of Resorcinol (Cas No. 108-46-3) in F344/N Rats And B6c3f1 Mice (Gavage Studies), U.S. Department Of Health And Human Services, Public Health Service, National Institutes of Health |
10. | Sodium selenite | Rat-Short Term | Dosed water | 002-02833-0003-0000-1 | 32 | 2 | 4 | Toxicity Studies of Sodium Selenate and Sodium Selenite (Cas Nos. 13410-01-0 And 10102-18-8) Administered in Drinking Water to F344/N Rats And B6c3f1 Mice, Kamal M. Abdo, Ph.D., Study Scientist, National Toxicology Program, Post Office Box 12233, Research Triangle Park, NC 27709, NIH Publication 94-3387, July 1994, United States Department of Health and Human Services, Public Health Service, National Institutes of Health |
11. | Tetrabromobisphenol A | Mouse-Short Term | Gavage | 002-02872-0004-0000-5 | 1000 | 10 | 100 | _____ |
12. | Tetrafluoroethylene | Rat-Chronic | INHALATION | 002-02886-0006-0000-2 | 1250 | 156 | 156 | Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (Cas No. 116-14-3) in F344/N Rats And B6c3f Mice1 (Inhalation Studies), National Toxicology Program, P.O. Box 12233, Research Triangle Park, NC 27709, April 1997, NTP TR 450, NIH Publication No. 97-3366, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health |
13. | Tricresyl phosphate | Rat-Chronic | Dosed feed | 002-02950-0007-0000-5 | 600 | 75 | 75 | Toxicology and Carcinogenesis, Studies of Tricresyl Phosphate, (Cas No. 1330-78-5), in F344/N Rats And B6c3f, Mice, (Gavage And Feed Studies), National Toxicology Program, Technical Report Series No. 433 |
14. | Trimethylolpropane triacrylate | Rat-Chronic | Skin application | 002-02968-0017-0000-5 | 0.3 | 1 | 0.3 | Toxicology and Carcinogenesis Studies of Trimethylolpropane Triacrylate, (Technical Grade), (Cas No. 15625-89-5) in F344/N Rats And B6c3f1/N Mice, Dermal Studie, National Toxicology Program, Research Triangle Park, NC 27709, December 2012 |
15. | Vinyl toluene | Rat-Chronic | Respiratory exposure whole body | 002-03003-0004-0000-2 | 300 | 100 | 100 | Toxicology and Carcinogenesis Studies of Vinyl Toluene (Mixed Isomers) (65%–71% Meta-Isomer And 32%–35% Para-Isomer) (Cas No. 25013-15-4) in F344/N Rats And B6c3f1 Mice (Inhalation Studies), U.S. Department of Health And Human Services, Public Health Service, National Institutes of Health |
Mouse-Chronic | Respiratory exposure whole body | 002-03003-0005-0000-3 | 25 | 10 | 25 | |||
16. | 1-Amino-2,4-dibromoanthraquinone | Rat-Chronic | Dosed feed | 002-01108-0006-0000-8 | 20,000 | 2,000 | 20,000 | Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (Cas No. 81-49-2) in F344/N Rats And B6c3f1 Mice (Feed Studies), U.S. Department Of Health And Human Services, Public Health Service, National Institutes of Health |
17. | 4,4′-Diamino-2,2′-stilbenedisulfonic acid, disodium salt | Mouse-Chronic | Dosed feed | 002-01460-0001-0000-4 | 12500 | 6250 | 6250 | Toxicology and Carcinogenesis Studies of 4,4′-Diamino-2,2′-Stilbenedisulfonic Acid, Disodium Salt (Cas No. 7336-20-1) in F344/N Rats and B6c3f1 Mice, (Feed Studies), U.S. Department of Health And Human Services, Public Health Service, National Institutes of Health |
18. | p-Nitrobenzoic acid | Mouse-Chronic | Dosed feed | 002-03178-0010-0000-2 | 5000 | 1250 | 1250 | Toxicology and Carcinogenesis Studies of P-Nitrobenzoic Acid (Cas No. 62-23-7) in F344/N Rats And B6c3fl Mice (Feed Studies), U.S. Department of Health And Human Services, Public Health Service, National Institutes of Health |
19. | p-Nitrotoluene | Mouse | Dosed feed | 002-02576-0015-0000-8 | 5000 | 1250 | 1250 | Toxicology and Carcinogenesis Studies of P-Nitrotoluene (Cas No. 99-99-0) in F344/N Rats And B6c3f1 Mice (Feed Studies) National Toxicology Program, P.O. Box 12233, Research Triangle Park, Nc 27709, May 2002, NTP TR 498, NIH Publication No. 02-4432, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health |
20. | 2-Methylimidazole | Rat-Chronic | Dosed feed | 002-01360-0011-0000-4 | 5000 | 300 | 1000 | Toxicology and Carcinogenesis Studies of 2-Methylimidazole (Cas No. 693-98-1) in F344/N Rats And B6c3f1 Mice (Feed Studies), National Toxicology Program, P.O. Box 12233, Research Triangle Park, Nc 27709, December 2004, NTP TR 516, NIH Publication No. 05-4456, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health |
21. | Methyl isobutyl ketone | Mouse-Chronic | Respiratory exposure whole body | 002-02438-0003-0000-2 | 1800 | 450 | 900 | Toxicology and Carcinogenesis Studies of Methyl Isobutyl Ketone (Cas No. 108-10-1) in F344/N Rats And B6c3f1 Mice (Inhalation Studies), National Toxicology Program, P.O. Box 12233, Research Triangle Park, NC 27709, February 200, NTP TR 538, NIH Publication No 07-4476, National Institutes of Health, Public Health Service, U.S. Department of Health and Human Services |
22. | Toluene | Rat-Chronic | Respiratory exposure whole body | 002-02916-0005-0000-5 | 1200 | 600 | 600 | Toxicology and Carcinogenesis Studies of Toluene (Cas No. 108-88-3) in F344/N Rats And B6c3fi Mice (Inhalation Studies), U.S. Department of Health And Human Services, Public Health Service National Institutes of Health |
Mouse-Chronic | Respiratory exposure whole body | 002-02916-0006-0000-6 | 1200 | 120 | 600 | |||
23. | Barium chloride dehydrate | Rat-Chronic | Dosed water | 002-01684-0004-0000-5 | 2500 | 500 | 500 | Toxicology and Carcinogenesis Studies of Barium chloride dihydrate (Cas No. 10326-27-9) In F344/N Rats And B6c3fl Mice (Drinking Water Studies), U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Toxicology Program, Technical Report Series No.432 |
24. | Styrene-acrylonitrile trimer | Rat-Short term | Dosed feed | 002-02846-0004-0000-6 | 4000 | 250 | 250 | Toxicology and Carcinogenesis Study of Styrene-acrylonitrile trimer in F344/N Rats (Perinatal And Postnatal Feed Studies), National Toxicology Program, P.O. Box 12233, Research Triangle Park, NC 27709, July 2012, NTP TR 573, NIH Publication No. 12-5915, National Institutes of Health, Public Health Service, U.S. Department of Health and Human Services |
25. | Decalin | Mouse-Chronic | Respiratory exposure whole body | 002-01965-0013-0000-7 | 400 | 25 | 100 | Toxicology and Carcinogenesis Studies of Decalin (Cas No. 91-17-8) in F344/N Rats and B6c3f1 Mice and a Toxicology Study of Decalin In Male NBR Rats (Inhalation Studies), National Toxicology Program, P.O. Box 12233, Research Triangle Park, NC 27709, January 2005, NTP TR 513, NIH Publication No. 05-4447, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health |
26. | 3,3′-Dimethoxybenzidine dihydrochloride | Rat-Chronic | Dosed water | 002-01389-0009-0000-2 | 330 | 80 | 80 | Toxicology and Carcinogenesis Studies of 3,3′-Dimethoxybenzidine dihydrochloride (Cas No. 20325-40-0) in F344/N Rats (Drinking Water Studies), U.S. Department of Health And Human Services, Public Health Service, National Institutes of Health |
27. | Bis(2-Chloroethoxy)methane | Rat-Chronic | Skin application | 002-03051-0014-0000-6 | 300 | 75 | 75 | Toxicology and Carcinogenesis Studies of Bis(2-chloroethoxy)methane (Cas No. 111-91-1) in F344/N Rats and B6c3f1 Mice (Dermal Studies), National Toxicology Program, P.O. Box 12233, Research Triangle Park, NC 27709, August 2011, NTP TR 536, NIH Publication No. 11-5904, National Institutes of Health Public Health Service, U.S. Department of Health And Human Services |
28. | 1-Bromopropane | Mouse-Chronic | Respiratory exposure whole body | 002-01113-0014-0000-3 | 250 | 62.5 | 62.5 | Toxicology and Carcinogenesis Studies of 1-Bromopropane (Cas No. 106-94-5) in F344/N Rats And B6c3f1 Mice (Inhalation Studies), National Toxicology Program, P.O. Box 12233, Research Triangle Park, NC 27709, August 2011, NTP TR 564, NIH Publication No. 11-5906, National Institutes of Health Public Health Service, U.S. Department Of Health And Human Services |
29. | Tribromomethane | Mouse-Chronic | Gavage | 002-02934-0011-0000-2 | 200 | 50 | 50 | Toxicology And Carcinogenesis Studies of Tribromomethane (Bromoform) (Cas No. 75-25-2) in F344/N Rats And B6c3fi Mice (Gavage Studies), U.S. Department of Health And Human Services, Public Health Service, National Institutes Of Health |
30. | Sodium dichromate dihydrate (VI) | Rat-Chronic | Dosed water | 002-02819-0022-0000-6 | 516 mg/L | 14.3 mg/L | 14.3 mg/L | The Toxicity Studies of Sodium dichromate dehydrate (Cas No. 7789-12-0) Administered in Drinking Water to Male and Female F344/N Rats And B6c3f1 Mice and Male BALB/C And Am3-C57bl/6 Mice, January 2007, National Institutes of Health, Public Health Service, U.S. Department of Health And Human Services |
31. | 1,2-Dihydro-2,2,4-trimethylquinoline (monomer) | Mouse-Long term | Dermal | 002-01051-0016-0000-6 | 10 | 3.6 | 3.6 | _____ |
Chemicals are arranged in alphabetic order and their LELs, study design and species are provided according to the screened CEBS studies.
Table 3.
# | Chemical Name | Study Design and species | LEL |
---|---|---|---|
1. | Polysorbate 80 | Rat-Chronic | 25,000 mg/kg |
2. | T-Butylhydroquinone | Mouse-Chronic | 1,250 mg/kg |
3. | Benzophenone | Rat-Chronic | 312 mg/kg |
4. | Cumene hydroperoxide | Rat-Short term | 100 mg/kg |
5. | Isobutyl nitrite | Mouse-Chronic Rat-Chronic |
37.5 mg/kg |
6. | N,N-Dimethyl-p-toluidine | Rat-Chronic | 6 mg/kg |
7. | Sodium azide | Rat-Chronic | 5 mg/kg |
8. | Tetranitromethane | Rat-Chronic | 2 mg/kg |
9. | Vanadium oxide | Mouse-Chronic | 1 mg/M3 |
10. | Nickel (II) oxide | Rat-Chronic | 0.63 mg/m3 |
11. | Nickel sulfate hexahydrate | Rat-Chronic | 0.25 mg/m3 |
12. | Indium phosphide | Rat-Chronic | 0.03 mg/m3 |
13. | Gallium arsenide | Rat-Chronic | 0.01 mg/M3 |
14. | 3,3′-Dimethylbenzidine dihydrochloride | Rat-Chronic | 0.003** |
Chemicals are arranged in alphabetic order and their LELs, study design and species are provided according to the screened CEBS studies.
Units were not provided in the CEBS search.
Table 4.
# | Chemical Name | Study Design and species | LEL (mg/kg) |
---|---|---|---|
1. | 1,2-Dibromo-2,4-dicyanobutane | Rat-Chronic | 2 |
2. | 1,2,3-Trichloropropane | Mouse-Chronic | 6 |
3. | 1,2,3-Trichloropropane | Rat-Chronic | 3 |
4. | 3,3′,4,4′-Tetrachloroazobenzene | Rat-Chronic | 10 |
5. | Beta-Picoline | Rat-Chronic | 312.5 mg/L |
6. | Formamide | Rat-Chronic | 20 |
7. | Fumonisin B1 | Mouse-Chronic | 80 |
8. | Hexachloroethane | Rat-Chronic | 10 |
9. | Monochloroacetic acid | Rat-Chronic | 10 |
10. | Naphthalene | Rat-Chronic | 10 |
11. | p,p′-Dichlorodiphenyl sulfone | Mouse-Chronic | 30 |
12. | Triethanolamine | Mouse-Chronic | 630 |
Pesticides are arranged in alphabetic order and their LELs, study design and species are provided according to the screened CEBS studies.
Table 5.
# | Chemical Name | Study Design and species | LEL (mg/kg) |
---|---|---|---|
1. | 3,4-Dihydrocoumarin | Mouse-Chronic | 200 |
2. | Beta-Myrcene | Mouse-Chronic | 250 |
3. | Dipropylene glycol | Rat-Chronic | 25,000 |
4. | Estragole | Mouse-Short term | 37.5 |
5. | Hydroquinone | Rat-Chronic | 25 |
6. | Isoeugenol | Rat-Chronic Mouse-Chronic |
75 |
7. | Methyl trans-styryl ketone | Mouse-Chronic | 10 |
8. | Methyleugenol | Rat-Short term | 150 |
9. | Tris(2-Chloroethyl) phosphate | Rat-Chronic | 44 |
Chemicals are arranged in alphabetic order and their LELs, study design and species are provided according to the screened CEBS studies.
Table 6.
# | Chemical Name | Study Design and species | LEL (mg/kg) |
---|---|---|---|
1. | 2-Butoxyethanol | Rat-Chronic | 31.2 |
2. | 2,4-Diaminophenol dihydrochloride | Mouse-Chronic | 0.038 |
3. | Benzyl acetate | Rat-Chronic | 3,000 |
4. | C.I. Acid red 114 | Rat-Chronic | 0.007 |
5. | C.I. Direct blue 15 | Rat-Chronic | 0.125** |
6. | C.I. Direct blue 218 | Rat-Chronic Mouse-Chronic |
1,000 |
7. | HC yellow 4 | Rat-Chronic | 25,000 |
8. | Malachite green | Rat-Chronic | 600 |
9. | Pyrogallol | Rat-Chronic | 5 |
Chemicals are arranged in alphabetic order and their LELs, study design and species are provided according to the screened CEBS studies.
Units were not provided in the CEBS search.
Table 7.
# | Chemical Name | Study Design and species | LEL (mg/kg) |
---|---|---|---|
1. | 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) | Rat-Chronic | 0.01 |
2. | Dioxin mixture | Rat-Chronic | 10 |
3. | PCB 118 | Rat-Chronic | 0.1 |
4. | PCB 126 | Rat-Chronic | 0.00001 |
5. | PCB 153 | Rat-Chronic | 0.01 |
6. | Pentachlorodibenzofuran (PECDF) | Rat-Chronic | 0.000006 |
Chemicals are arranged in alphabetic order and their LELs, study design and species are provided according to the screened CEBS studies.
Acknowledgments
This work was supported in part by NIHS grants R01ES021375 (Cave, Prough), 5T35ES011564 (Prough) and K23AA018399 (Cave).
Abbreviations
- TASH
Toxicant Associated Steatohepatitis
- NASH
Non-alcoholic Steatohepatitis
- NAFLD
Non-alcoholic fatty liver disease
- TAFLD
Toxicant associated fatty liver disease
- ToxRefDB
Toxicological Reference Database
- CEBS
Chemical Effects in Biological Systems
- VC
Vinyl Chloride
- PCBs
Polychlorinated biphenyls
- NHANES
National Health and Nutrition Examination Survey
- LEL
lowest effect dose
- NIH
National Institutes of Health
- CRN
Clinical Research Network
- NTP
National Toxicology Program
- EPA
Environmental Protection agency
- CAS
Chemical Abstracts Service
Footnotes
The authors declare they have no actual or potential competing financial interests.
References
- EPA, United States Environmental Protection Agency. Computational Toxicology Research Program: ToxRefDB. 2013 http://www.epa.gov/ncct/toxrefdb/
- Amin KA, Abdel Hameid H, 2nd, Abd Elsttar AH. Effect of food azo dyes tartrazine and carmoisine on biochemical parameters related to renal, hepatic function and oxidative stress biomarkers in young male rats. Food Chem Toxicol. 2010;48:2994–2999. doi: 10.1016/j.fct.2010.07.039. [DOI] [PubMed] [Google Scholar]
- Angrish MM, Dominici CY, Zacharewski TR. TCDD-elicited effects on liver, serum, and adipose lipid composition in C57BL/6 mice. Toxicological sciences : an official journal of the Society of Toxicology. 2013;131:108–115. doi: 10.1093/toxsci/kfs277. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Angrish MM, Mets BD, Jones AD, Zacharewski TR. Dietary Fat Is a Lipid Source in 2,3,7,8-Tetrachlorodibenzo-rho-Dioxin (TCDD)-Elicited Hepatic Steatosis in C57BL/6 Mice. Toxicol Sci. 2012;128:377–386. doi: 10.1093/toxsci/kfs155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Authority, C.R.S.N.R. NRA Report on the Special Review of Metham Sodium, Dazomet and Methylisothiocyanate (MITC) Australia, C.O: 1997. [Google Scholar]
- Bieghs V, Shiri-Sverdlov R. Research on Diabetes I. 2014. Animal Models of Non-alcoholic Fatty Liver Disease: from Genetics to Nutrition. [Google Scholar]
- Brautbar N, Williams J., 2nd Industrial solvents and liver toxicity: risk assessment, risk factors and mechanisms. Int J Hyg Environ Health. 2002;205:479–491. doi: 10.1078/1438-4639-00175. [DOI] [PubMed] [Google Scholar]
- CAS, C.A.S. CAS REGISTRY - The gold standard for chemical substance information. 2014 https://www.cas.org/content/chemical-substances.
- Cave M, Appana S, Patel M, Falkner KC, McClain CJ, Brock G. Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003–2004. Environ Health Persp. 2010a;118:1735–1742. doi: 10.1289/ehp.1002720. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cave M, Falkner KC, Henry L, Costello B, Gregory B, McClain CJ. Serum cytokeratin 18 and cytokine elevations suggest a high prevalence of occupational liver disease in highly exposed elastomer/polymer workers. J Occup Environ Med. 2011a;53:1128–1133. doi: 10.1097/JOM.0b013e31822cfd68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cave M, Falkner KC, Ray M, Joshi-Barve S, Brock G, Khan R, Bon Homme M, McClain CJ. Toxicant-associated steatohepatitis in vinyl chloride workers. Hepatology. 2010b;51:474–481. doi: 10.1002/hep.23321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cave M, Falkner KC, McClain . A Textbook of Liver Disease (Hepatology) Elsevier Saunders; Philadelphia, PA: 2011. Occupational and Environmental Hepatotoxicity; pp. 476–492. [Google Scholar]
- Cave MC, Beier JI, Wheeler B, Falkner KC, Bellis-Jones HJ, Clair HB, McClain CJ. Occupational Vinyl Chloride Exposures Are Associated With Significant Changes To The Plasma Metabolome: Implications For Toxicant Associated Steatohepatitis. Hepatology. 2012;56:882A–883A. [Google Scholar]
- Cave MC, Falkner KC, Costello B, McClain CJ. Serum Cytokeratin 18 and Cytokine Elevations Suggest a High Prevalence of Occupational Liver Disease in Elastomer/Polymer Workers Highly Exposed to Acrylonitrile, Butadiene and Styrene. Gastroenterology. 2011b;140:S975–S975. doi: 10.1097/JOM.0b013e31822cfd68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cotrim HP, Andrade ZA, Parana R, Portugal M, Lyra LG, Freitas LA. Nonalcoholic steatohepatitis: a toxic liver disease in industrial workers. Liver. 1999;19:299–304. doi: 10.1111/j.1478-3231.1999.tb00053.x. [DOI] [PubMed] [Google Scholar]
- Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114:842–845. doi: 10.1016/s0016-5085(98)70599-2. [DOI] [PubMed] [Google Scholar]
- Dossing M, Arlien-Soborg P, Milling Petersen L, Ranek L. Liver damage associated with occupational exposure to organic solvents in house painters. Eur J Clin Invest. 1983;13:151–157. doi: 10.1111/j.1365-2362.1983.tb00080.x. [DOI] [PubMed] [Google Scholar]
- EPA, United States Environmental Protection Agency. RED Fact Sheet: Dazomet. 2008. [Google Scholar]
- EPA, United States Environmental Protection Agency. Hexaconazole (ANVIL 25 SC; ANVIL 25EC/OL» in or on Imported Bananas. 1999. [Google Scholar]
- Hester SD, Wolf DC, Nesnow S, Thai SF. Transcriptional profiles in liver from rats treated with tumorigenic and non-tumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil. Toxicol Pathol. 2006;34:879–894. doi: 10.1080/01926230601047824. [DOI] [PubMed] [Google Scholar]
- Kleiner DE, Brunt EM. Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis. 2012;32:3–13. doi: 10.1055/s-0032-1306421. [DOI] [PubMed] [Google Scholar]
- Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ Nonalcoholic Steatohepatitis Clinical Research, N. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–1321. doi: 10.1002/hep.20701. [DOI] [PubMed] [Google Scholar]
- Lee JH, Wada T, Febbraio M, He J, Matsubara T, Lee MJ, Gonzalez FJ, Xie W. A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis. Gastroenterology. 2010;139:653–663. doi: 10.1053/j.gastro.2010.03.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434–438. [PubMed] [Google Scholar]
- Martin MT, Judson R, Richard AM, Houck KA, Dix DJ. ToxRefDB: Linking regulatory toxicology information on environmental chemicals with high-throughput screening (HTS) and genomic data. International Science Forum on Computational Toxicology; RTP, NC. May 21–23.2007. [Google Scholar]
- Martin MT, Mendez E, Corum DG, Judson RS, Kavlock RJ, Rotroff DM, Dix DJ. Profiling the reproductive toxicity of chemicals from multigeneration studies in the toxicity reference database. Toxicological sciences : an official journal of the Society of Toxicology. 2009;110:181–190. doi: 10.1093/toxsci/kfp080. [DOI] [PubMed] [Google Scholar]
- McGonigle P, Ruggeri B. Animal models of human disease: challenges in enabling translation. Biochem Pharmacol. 2014;87:162–171. doi: 10.1016/j.bcp.2013.08.006. [DOI] [PubMed] [Google Scholar]
- National Toxicology, P. Toxicology and carcinogenesis studies of 2,3′,4,4′,5-pentachlorobiphenyl (PCB 118) (CAS No. 31508-00-6) in female harlan Sprague-Dawley rats (gavage studies) Natl Toxicol Program Tech Rep Ser. 2010:1–174. [PubMed] [Google Scholar]
- Nebert DW, Gonzalez FJ. P450 genes: structure, evolution, and regulation. Annual review of biochemistry. 1987;56:945–993. doi: 10.1146/annurev.bi.56.070187.004501. [DOI] [PubMed] [Google Scholar]
- Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 1996;6:1–42. doi: 10.1097/00008571-199602000-00002. [DOI] [PubMed] [Google Scholar]
- NTP. New CEBS File Assists Database Collaboration. http://ntp.niehs.nih.gov/?objectid=29376036-D423-4AC0-55E9F014611F94B3.
- Peffer RC, Moggs JG, Pastoor T, Currie RA, Wright J, Milburn G, Waechter F, Rusyn I. Mouse liver effects of cyproconazole, a triazole fungicide: role of the constitutive androstane receptor. Toxicological sciences : an official journal of the Society of Toxicology. 2007;99:315–325. doi: 10.1093/toxsci/kfm154. [DOI] [PubMed] [Google Scholar]
- Prince MI, Ducker SJ, James OF. Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations. Gut. 2010;59:508–512. doi: 10.1136/gut.2009.184218. [DOI] [PubMed] [Google Scholar]
- Reigart JRRaJR. Recognition and management of pesticide poisonings. The National Association of State Departments of Agriculture Research Foundation (NASDARF); 2013. Fungicides; pp. 143–116. [Google Scholar]
- Sciences, N.I.O.H. Chemical Effects in Biological Systems (CEBS) 2012 http://www.niehs.nih.gov/research/resources/databases/cebs/
- Shi X, Wahlang B, Wei X, Yin X, Falkner KC, Prough RA, Kim SH, Mueller EG, McClain CJ, Cave M, Zhang X. Metabolomic analysis of the effects of polychlorinated biphenyls in nonalcoholic fatty liver disease. J Proteome Res. 2012;11:3805–3815. doi: 10.1021/pr300297z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Silberhorn EM, Glauert HP, Robertson LW. Carcinogenicity of polyhalogenated biphenyls: PCBs and PBBs. Critical reviews in toxicology. 1990;20:440–496. doi: 10.3109/10408449009029331. [DOI] [PubMed] [Google Scholar]
- Soyinka OO, Adeniyi FA, Ajose OA. Biochemical parameters of liver function in artisans occupationally exposed to “vat dyes”. Indian J Occup Environ Med. 2007;11:76–79. doi: 10.4103/0019-5278.34533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tolman KG, Sirrine R. Occupational hepatotoxicity. Clin Liver Dis. 1998:563–589. [Google Scholar]
- Tomei F, Giuntoli P, Biagi M, Baccolo TP, Tomao E, Rosati MV. Liver damage among shoe repairers. Am J Ind Med. 1999;36:541–547. doi: 10.1002/(sici)1097-0274(199911)36:5<541::aid-ajim6>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
- Wahlang B, Beier JI, Clair HB, Bellis-Jones HJ, Falkner KC, McClain CJ, Cave MC. Toxicant-associated steatohepatitis. Toxicol Pathol. 2013;41:343–360. doi: 10.1177/0192623312468517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wahlang B, Zhang X, Falkner KC, McClain CJ, Cave MC. Polychlorinated Biphenyl 153 Worsens Hepatic Steatosis in Mice Fed a High Fat Diet and Differentially Regulates 40 Liver Metabolites: Preliminary Results of a Metabolomics Analysis. Hepatology. 2011;54:1156A–1156A. [Google Scholar]
- Waters M, Stasiewicz S, Merrick BA, Tomer K, Bushel P, Paules R, Stegman N, Nehls G, Yost KJ, Johnson CH, Gustafson SF, Xirasagar S, Xiao N, Huang CC, Boyer P, Chan DD, Pan Q, Gong H, Taylor J, Choi D, Rashid A, Ahmed A, Howle R, Selkirk J, Tennant R, Fostel J. CEBS--Chemical Effects in Biological Systems: a public data repository integrating study design and toxicity data with microarray and proteomics data. Nucleic Acids Res. 2008;36:D892–900. doi: 10.1093/nar/gkm755. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yilmaz Y. Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? Aliment Pharmacol Ther. 2012;36:815–823. doi: 10.1111/apt.12046. [DOI] [PubMed] [Google Scholar]
- Yu ML, Guo YL, Hsu CC, Rogan WJ. Increased mortality from chronic liver disease and cirrhosis 13 years after the Taiwan “yucheng” (“oil disease”) incident. Am J Ind Med. 1997;31:172–175. doi: 10.1002/(sici)1097-0274(199702)31:2<172::aid-ajim6>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
- Zimmerman HJ. Hepatotoxicity : the adverse effects of drugs and other chemicals on the liver. Lippincott Williams & Wilkins; Philadelphia: 1999. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.